Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CLIC-2201 |
Synonyms | |
Therapy Description |
Limited information is currently available on CLIC-2201, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD22 (Feb 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CLIC-2201 | CLIC 2201|CLIC2201 | CD22 Immune Cell Therapy 15 | Limited information is currently available on CLIC-2201, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD22 (Feb 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06208735 | Phase I | CLIC-2201 | CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies | Not yet recruiting | CAN | 0 |